Safety and efficacy of droxidopa (Norther™) for the treatment of symptomatic neurogenic orthostatic by (NOH) in patients with Parkinson's disease (PD)

被引：0
|
作者：
Mathias, C. J.
Kaufmann, H.
机构：
来源：
MOVEMENT DISORDERS | 2010年 / 25卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S405 / S406
页数：2
相关论文
共 50 条
  • [31] Persistence of Droxidopa Treatment in Patients With Neurogenic Orthostatic Hypotension
    Basile, Jan
    Kymes, Steven
    Jackson, Kenneth
    Widolff, Michelle
    NEUROLOGY, 2018, 90
  • [32] Neurogenic orthostatic hypotension in Parkinson's disease: evaluation, management, and emerging role of droxidopa
    Isaacson, Stuart H.
    Skettini, Julia
    VASCULAR HEALTH AND RISK MANAGEMENT, 2014, 10 : 169 - 176
  • [33] Persistence of Droxidopa Treatment in Patients With Neurogenic Orthostatic Hypotension
    Basile, J.
    Kymes, S.
    Jackson, K.
    Widolff, M.
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2018, 66 : S241 - S241
  • [34] Meta-analysis of the safety and efficacy of droxidopa for neurogenic orthostatic hypotension
    Elgebaly, Ahmed
    Abdelazeim, Bassant
    Mattar, Omar
    Gadelkarim, Mohamed
    Salah, Rehab
    Negida, Ahmed
    CLINICAL AUTONOMIC RESEARCH, 2016, 26 (03) : 171 - 180
  • [35] Meta-analysis of the safety and efficacy of droxidopa for neurogenic orthostatic hypotension
    Ahmed Elgebaly
    Bassant Abdelazeim
    Omar Mattar
    Mohamed Gadelkarim
    Rehab Salah
    Ahmed Negida
    Clinical Autonomic Research, 2016, 26 : 171 - 180
  • [36] Durability of Effect With Long-Term Droxidopa Treatment in Patients with Symptomatic Neurogenic Orthostatic Hypotension
    Isaacson, Stuart
    Lisk, Jerome
    Liang, Grace
    Rowse, Gerald
    NEUROLOGY, 2016, 86
  • [37] Analysis of efficacy in patients with symptomatic neurogenic orthostatic hypotension treated with droxidopa and dopa-decarboxylase inhibitors
    Biaggioni, I.
    Low, P.
    Rowse, G.
    Kaufmann, H.
    MOVEMENT DISORDERS, 2012, 27 : S422 - S423
  • [38] Analysis of number needed to treat for droxidopa in patients with symptomatic neurogenic orthostatic hypotension
    Clément François
    Gerald J. Rowse
    L. Arthur Hewitt
    Pamela Vo
    Robert A. Hauser
    BMC Neurology, 16
  • [39] Analysis of number needed to treat for droxidopa in patients with symptomatic neurogenic orthostatic hypotension
    Francois, Clement
    Rowse, Gerald J.
    Hewitt, L. Arthur
    Vo, Pamela
    Hauser, Robert A.
    BMC NEUROLOGY, 2016, 16
  • [40] Randomized Withdrawal Study of Patients With Symptomatic Neurogenic Orthostatic Hypotension Responsive to Droxidopa
    Biaggioni, Italo
    Freeman, Roy
    Mathias, Christopher J.
    Low, Phillip
    Hewitt, L. Arthur
    Kaufmann, Horacio
    HYPERTENSION, 2015, 65 (01) : 101 - +
12345